What is Aclaris Therapeutics's free cash flow yield?

Aclaris Therapeutics (ACRS) reported free cash flow yield of -11.5% in Q1 2026.

What is the long-term trend for Aclaris Therapeutics's free cash flow yield?

Over 3 years (2020 to 2025), Aclaris Therapeutics's free cash flow yield has grown at a 13.6% compound annual growth rate (CAGR), from -9.9% to -14.5%.

What does free cash flow yield mean?

Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.

Aclaris Therapeutics ACRS Free cash flow yield

Free cash flow yield at other companies

IncyteINCY

8.1%+4.9pp

Corvus PharmaceuticalsCRVS

-2.9%—

Avalo TherapeuticsAVTX

-63.1%-29.0pp

Shattuck Labs, Inc.STTK

-9%-4.3pp

Apogee Therapeutics, Inc.APGE

-4.5%-1.1pp

Kymera TherapeuticsKYMR

-3.6%-1.5pp

Other financials

Income statement

See full

Revenue$2.0M+37.2%

Gross profit$1.6M+68.7%

Operating income-$22.2M-22.7%

Net income-$19.8M-31.4%

EPS (diluted)-$0.15-25.0%

Balance sheet

See full

Cash & equivalents$28.7M-5.6%

Total debt$2.0M-20.1%

Total equity$143.6M-0.3%

Total assets$198.7M+0.3%

Cash flow

See full

Operating cash flow-$18.1M-39.0%

CapEx$13.0K-69.8%

Free cash flow-$18.2M-38.6%

Valuation

See full

Market cap$685.75M+337%

Enterprise value$659.07M+410%

P/S82×+73.1×

Profitability

See full

Gross margin76.3%-9.7pp

Operating margin-961.9%+259pp

Net margin-832.6%+132pp

FCF margin-624.9%—

Returns & leverage

See full

Return on equity-48.4%-15.4pp

Debt / equity0×0.0×

Current ratio4×-1.0×

Where this comes from

Calculated from Aclaris Therapeutics’s reported figures.

free cash flow/market cap=-11.5%

Based on trailing twelve months.

The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aclaris Therapeutics's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aclaris Therapeutics's free cash flow yield?: Aclaris Therapeutics (ACRS) reported free cash flow yield of -11.5% in Q1 2026.
What is the long-term trend for Aclaris Therapeutics's free cash flow yield?: Over 3 years (2020 to 2025), Aclaris Therapeutics's free cash flow yield has grown at a 13.6% compound annual growth rate (CAGR), from -9.9% to -14.5%.
What does free cash flow yield mean?: Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.